期刊文献+

随机组合多表位恶性疟疾疫苗M.RCAg-1蛋白的纯化及鉴定 被引量:1

Purification and Identification of Randomly Recombinant Multiepitope Protein M.RCAg-1 of Plasmodium falciparum Vaccine
原文传递
导出
摘要 目的纯化随机组合多表位恶性疟疾疫苗M.RCAg-1蛋白,并进行各项鉴定。方法对BL21(DE3)-M.RCAg-1/pDS-ex工程菌发酵产物进行纯化,对纯化的M.RCAg-1蛋白进行各种理化性质鉴定;采用Western blot法检测其反应原性;以不同剂量的M.RCAg-1蛋白免疫BALB/c小鼠及新西兰大白兔,采用间接ELISA法检测小鼠血清抗体效价;间接荧光免疫法(IFA)分析免疫血清对天然疟原虫抗原的识别;酶联免疫斑点试验检测特异性鼠T淋巴细胞的活化及细胞因子的分泌;体外生长抑制试验检测免疫兔血清对恶性疟原虫生长的影响。结果 M.RCAg-1蛋白表达量约为菌体总蛋白的30%,浓度为1.5 mg/ml,纯度可达95%左右,等电点为5.0;内毒素残留量均小于2.5 EU/mg,宿主蛋白残留量为0.08%,N-末端氨基酸序列正确;可与相应鼠单抗特异性结合;免疫小鼠血清抗体水平随着免疫次数和免疫剂量的增加而升高,20及30μg剂量组在末次免疫后,血清抗体滴度均可达1∶1 031 707;各免疫组小鼠血清均能识别恶性疟原虫天然抗原,且呈抗原剂量依赖性;10、20和30μg剂量组能刺激相应特异性脾淋巴细胞显著增殖(P<0.01)及分泌IFNγ和IL-4(P<0.01),并能较好地抑制疟原虫体外生长。结论纯化的M.RCAg-1蛋白理化性质稳定,具有较强的免疫原性,能激发可持续、高滴度的特异性抗体,并能诱发显著的T细胞应答,是极具潜力的候选疫苗蛋白,具有较好的开发前景。 Objective To purify and identify the randomly recombinant multiepitope protein M.RCAg-1 of Plasmodium falciparum vaccine.Methods The fermentation product of recombinant E.coli BL21(DE3)-M.RCAg-1 / pDS-ex was purified,then investigated for physic-chemical property and determined for reactogenicity by Western blot.BALB / c mice and New Zealand rabbits were immunized with M.RCAg-1 protein at various dosages,and determined for antibody titer in sera by indirect ELISA.The recognition of natural parasite antigen with the immune sera was determined by IFA.The activation of mouse specific T lymphocytes and secretion of cytokines were determined by enzyme-linked immunosorbent spot test.The effect on growth of Plasmodium falciparum was observed by growth inhibition test in vitro.Results The M.RCAg-1 protein,with an isoelectric point of 5.0,contained about 30% of total somatic protein,reached a purity of more than 95% and showed specific reaction with mouse specific monoclonal antibody,of which the concentration was 1.5 mg / ml,the residual endotoxin content was less than 2.5 EU / mg,the residual host protein content of 0.08%,and the amino acid sequence at N-terminus was correct.The serum antibody titer increased with the increasing doses and dosages of M.RCAg-1 protein,while those after last immunization with 20 and 30 μg of M.RCAg-1 protein reached 1 ∶ 1 031 707.All the immune sera of mice recognized the natural antigen of Plasmodium falciparum in a dose-dependent mode,while those induced by 10,20 and 30 μg of M.RCAg-1 protein stimulated the proliferation of specific splenic lymphocytes(P 0.01) as well as secretions of IFNγ and IL-4(both P 0.01),and inhibited the growth of Plasmodium falciparum in vitro significantly.Conclusion The purified M.RCAg-1 protein showed stable physic-chemical property and high immunogenicity,stimulated persistent high titer specific antibody and induced significant T cell response,which might be used as a potential candidate vaccine of good prospect of development.
出处 《中国生物制品学杂志》 CAS CSCD 2011年第12期1391-1395,1399,共6页 Chinese Journal of Biologicals
基金 863计划"疫苗与抗体工程"重大专项(2006AA02A224) "艾滋病和病毒性肝炎等重大传染病防治"科技重大专项(2008ZX10004-015)
关键词 M.RCAg-1蛋白 多表位蛋白 疟疾疫苗 M.RCAg-1 protein Multiepitope protein Malaria vaccine
  • 相关文献

参考文献11

  • 1Waters A. Malaria: new vaccines for old [J]. Cell, 2006, 124 (4): 689-693.
  • 2Greenwood BM, Targett GA. Malaria vaccines and the new malaria agenda [J].Clin Microbiol Infect, 2011,17 ( 11 ) : 1600-1607.
  • 3Cai QL, Wei F, Lin YH, et al. Immunogenicity of polyepitope libraries assembled by epitope shuffling: an approach to the development of chimeric gene vaccination against malaria [J].Vaccine, 2004, 23 (2) : 267-277.
  • 4Li WL, Liu EX, Fan RG, et al. Characterization of plasmodium yoelii antigens by monoclonal antibodies, I , Common antigens between erythrocytic stages 9f plasmodium yoelii and human malaria parasites [J]. Ji Sheng Chong Xue /de Ji Sheng Chong Bing Za Zhi, 1984,2(2) : 83-87.
  • 5孙成金,王健,丁军颖,郭鹏,郑凡,张振龙.多表位恶性疟疾疫苗M.RCAg-1在大肠杆菌表达的条件优化和大规模培养[J].微生物学免疫学进展,2009,37(3):29-33. 被引量:2
  • 6Yang T, Wang HN, Wang X, et al, Multivalent DNA vaccine enhanced protection efficacy against infectious bronchitis virus in chickens [J]. J Vet Med Sci, 2009, 71 (12): 1585-1590.
  • 7Takala SL, Plowe CV. Genetic diversity and malaria vaccine design, testing and efficacy: preventing and overcoming "vaccine resistant malaria [J]. Parasite Immund, 2009, 31 (9): 560-573.
  • 8Mahanty S, Saul A, Miller LH. Progress in the development of recombinant and synthetic blood-stage malaria vaccines [J]. J Exp Biol, 2003, 206 (Pt 21) :3781-3788.
  • 9Olugbile S, Villard V, Bertholet S, et al. Malaria vaccine candidate: design of a multivalent subunit alpha-helical coiled coil poly-epitope [J]. Vaecine, 2011,29 (40): 7090-7099.
  • 10Zhou Z, Todd CW, Wohlhueter RM, et ol. Development, characterization and immunogenicity of a multi-stage, multi-valent Plasmodium falciparum vaccine antigen (FALVAC-1A) expressed in Escherichia coli[J]. Hum Vaccin, 2006, 2( 1 ) : 14-23.

二级参考文献9

  • 1刘照惠,邵丽君,李猛,金立杰,李利,谷丽娟,赵晓琳,杨屹.HBV PreS2-MBP融合蛋白在大肠杆菌中表达条件的优化[J].中国生物制品学杂志,2007,20(6):435-438. 被引量:4
  • 2SnowRW, Guerra CA, Noor AM,et al. The global distribution of clinical episodes of PIasmodium falciparum malaria [ J ]. Nature 2005,434 (7030) :214- 217.
  • 3Cai QL, Wei F, Lin YH, et al. Immunogenicity of polyepitope libraries assembled by epitope shuffling: an approach to the development of chimeric gene vaccination against malaria [ J ]. Vaccine 2004,23(2) : 267- 277.
  • 4Cai QL, Peng G, Bu L, et al. Immunogenicity and in vitro protective efficacy of a polyepitope Plasmodium falciparum candidate vaccine constructed by epitope shuffling [ J ]. Vaccine 2007,25 (28) : 5155- 5165.
  • 5Zhou Z, Todd CW, Wohlhueter RM, et al. Development, characterization and immunogenicity of a multi-stage, multi-valent Plasmodium falciparum vaccine antigen ( FALVAC-1 A) expressed in Escherichia coli[J]. Hum Vaccin 2006,2(1 ) : 14- 23.
  • 6Dipti CA, Jain SK, Navin K. A novel recombinant multiepitope protein as a hepatitis C diagnostic intermediate of high sensitivity and specificity[J]. Protein Expr Purif 2006, 47(1) : 319- 328.
  • 7J 萨姆布鲁克,D W 拉塞尔.分子克隆实验指南[M].第3版.北京:科学出版社,2002:304-340.
  • 8汪永信,钟辉,曹诚,张艳红,张部昌,马清钧.pcD-awte候选疟疾DNA疫苗发酵条件的探索[J].生物学杂志,2007,24(5):16-19. 被引量:1
  • 9舒红,任常山.人神经生长因子的A-T克隆及在Pichia pastoris酵母中的表达(英文)[J].中国现代医学杂志,2004,14(11):21-25. 被引量:5

共引文献1

同被引文献2

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部